Literature DB >> 8914367

Erythema elevatum diutinum in human immunodeficiency virus-infected patients--report of a case and review of the literature.

F Dronda1, A González-López, M Lecona, C Barros.   

Abstract

Erythema elevatum diutinum (EED) is a rare chronic disease of unknown origin, part of the spectrum of cutaneous leucocytoclastic vasculitis. A case of EED in a 32-year-old HIV-infected male patient, with no previous opportunistic infections and a CD4+ cell count of less than 200/mm3, is reported. Therapy with oral dapsone (100 mg/day for 15 days) resulted in clinical cure with no relapse after 6 months of follow-up. To our knowledge, only six cases of EED in HIV-positive patients have been reported to date. A brief review of these seven cases is described.

Entities:  

Mesh:

Year:  1996        PMID: 8914367     DOI: 10.1111/j.1365-2230.1996.tb00069.x

Source DB:  PubMed          Journal:  Clin Exp Dermatol        ISSN: 0307-6938            Impact factor:   3.470


  4 in total

1.  Erythema elevatum diutinum involving palms and soles: a case report and literature review.

Authors:  Uma Keyal; Anil Kumar Bhatta; Yeqiang Liu
Journal:  Am J Transl Res       Date:  2017-04-15       Impact factor: 4.060

2.  Erythema elevatum diutinum in association with IgA monoclonal gammopathy: A rare case report.

Authors:  Guru Prasad Patnala; Anila P Sunandini; Rama Rayavarapu; Padmasri Somala Yandapalli
Journal:  Indian Dermatol Online J       Date:  2016 Jul-Aug

3.  Nodular Erythema Elevatum Diutinum Mimicking Kaposi's Sarcoma in a Human Immunodeficiency Virus Infected Patient.

Authors:  G Raghurama Rao; Rajiv Joshi; A Krishna Phaneendra Prasad; A Amareswar; S Sandhya; M Sridevi
Journal:  Indian J Dermatol       Date:  2014-11       Impact factor: 1.494

4.  Exuberant case of erythema elevatum diutinum in a patient infected with HIV and hepatitis B virus.

Authors:  Sayuri Aparecida Hirayama; Cezar Arthur Tavares Pinheiro; Isabelle Maffei Guarenti; Danise Senna Oliveira
Journal:  An Bras Dermatol       Date:  2020-02-12       Impact factor: 1.896

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.